人福医药索赔递交立案，符合要求的即可登记

Core Viewpoint - ST Renfu and its controlling shareholder, Contemporary Group, are facing legal actions due to multiple violations of information disclosure regulations, including non-operating fund occupation and false financial reporting [1][3][4] Group 1: Legal Proceedings - A lawsuit has been filed by the Shanghai Huzhi Law Firm on behalf of affected shareholders, and it is currently under judicial review [1][2] - Shareholders who purchased shares between April 27, 2021, and October 22, 2024, and incurred losses can join the legal action [3][4] Group 2: Violations Identified - Non-operating fund occupation amounted to 12.785 billion yuan, which was not disclosed in a timely manner, and the 2020 annual report omitted this information [2][4] - A property asset transaction worth 1.645 billion yuan between a subsidiary and related parties was not disclosed in the 2022 annual report [2][4] - Financial reports from 2020 to 2022 contained false records, inflating net profit by over 300 million yuan [2][4] - The Contemporary Group concealed related party relationships, resulting in a 100 million yuan equity acquisition transaction not being disclosed as required [2][4]